Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II prostate cancer trial of Atragen now in progress

Dec. 1, 1998

Combretastatin preclinical studies demonstrate antitumor efficacy when combined with radiation

Dec. 1, 1998

AN-9 compared to butyric acid and paclitaxel against primary human tumor colony-forming units

Dec. 1, 1998

GlycoDesign expands phase II cancer trial with GD0039

Nov. 30, 1998

New prodrugs of CPI derivatives designed by Kyorin and Sagami

Nov. 27, 1998

Access plans for clinical development of AP-5070

Nov. 27, 1998

Schering-Plough's p53 gene therapy continues to make impressive progress

Nov. 27, 1998

Onyx reports encouraging phase II results of ONYX-015 in head and neck cancer

Nov. 27, 1998

Novel antitumor vinca alkaloids patented by Pierre Fabre

Nov. 26, 1998

Onyx presents new addition to anticancer arsenal at gene therapy conference

Nov. 26, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...